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Summary It has been proposed that nm23-H1, a candidate suppressor gene for metastasis, plays an
important role in metastasis formation of human tumours. In order to investigate its role in the progression of
colorectal cancer, we analysed 22 liver metastases of this malignancy with respect to mutational changes, loss
of heterozygosity and expression levels of nm23-H 1. Although genetic alterations in nm23-H I have recently
been described in those colorectal adenocarcinomas which give rise to distant metastases, we were unable to
detect any mutation in the coding sequence of nm23-Hl in the metastatic tissue itself. We further analysed the
metastases with respect to allelic deletions at the chromosomal locus of nm23. However, no loss of
heterozygosity could be detected in ten informative cases. Moreover, the mRNA expression levels of nm23-Hl
in the metastatic tissues were not significantly different from those in normal colon mucosa. Thus, although
nm23-Hl might be involved in metastasis suppression of certain tumour types, in colorectal tumour progres-
sion its role remains to be determined.
The discovery of genetic alterations in oncogenes and
tumour-suppressor genes, which accompany tumour forma-
tion in a wide variety of human tumour types, has en-
couraged the search for genes that may promote or suppress
tumour spread and metastasis. Among these, nm23 seemed
to be the most promising candidate for a gene with
metastasis-suppressing function. There are two closely related
human homologues of this gene, called nm23-H1 and nm23-
H2, both of which map to the chromosomal locus 17q21.3
(Backer et al., 1993). Nm23 proteins have been demonstrated
to have nucleoside diphosphate kinase (NDP kinase) activity
(Biggs et al., 1990; Lacombe et al., 1990; Gilles et al., 1991)
and the human Nm23-H2 gene product has recently been
identified as the c-myc transcription factor PuF (Postel et al.,
1993).
Reduced expression levels of nm23-H1 mRNA and allelic
deletions at the chromosomal locus 17q21.3, which might
abrogate the suppressor function, have been implicated in
metastasis formation of several human tumour types
(Bevilacqua et al., 1989; Cohn et al., 1991; Hennessy et al.,
1991; Hirayama et al., 1991; Leone et al., 1991; Nakayama et
al., 1992). In breast carcinomas, for example, low nm23-Hl
mRNA levels have been associated with the presence of
lymph node metastases (Bevilacqua et al., 1989), while high
mRNA levels have been correlated with good prognosis
(Hennessy et al., 1991; Hirayama et al., 1991).
The data published so far, are, however, somewhat contra-
dictory, since increased nm23-H1 expression has been
observed in several tumour types, including colon cancer
(Haut et al., 1991; Lacombe et al., 1991; Myeroff & Mar-
kowitz, 1993). In some tumours this increased expression has
even been associated with poor prognosis. In neuroblastoma,
for instance, overexpression of the nm23-H1-encoded protein
has been correlated with advanced stage disease (Hailat et al.,
1991; Leone et al., 1993). In colon cancer, low expression
levels of nm23-H1 have been associated in metastasis forma-
tion in some studies (Yamaguchi et al., 1993), while other
groups did not find differences between the expression levels
of colon tumours with low and high metastatic potential
(Haut et al., 1991). Moreover, the role of mutations detected
in nm23 is controversial. Recently published data generated
on primary colon cancer suggest that mutations of nm23-H1
may be associated with metastasis (Wang et al., 1993). How-
ever, with the aid of screening methods, other groups were
unable to detect any mutation in both nm23 homologues in
primary colon carcinomas of low and high metastatic poten-
tial (Myeroff & Markowitz, 1993).
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To further clarify the role nm23-H1 mutations play in the
progression of colorectal cancer, we analysed metastases of
this malignancy. We sequenced the whole coding sequence of
nm23-Hl in 22 liver metastases and determined the allele
number at the nm23 locus. Furthermore, we measured nm23-
Hi-mRNA levels using a sensitive polymerase chain reaction
(PCR) assay and quantitative high-performance liquid
chromatography (HPLC).
Materials and methods
RNA isolation andsequencing
Fresh-frozen tumour tissues from 22 patients undergoing
abdominal surgery were sliced with a cryostat. Areas showing
a high tumour cell content were pooled; the tumour cell
content was estimated on the basis of haemalum-stained
tissue sections (Table I). Total RNA was isolated from
homogenised tissue (RNAzol-kit/Cinna Biotecx Laboratories,
Houston, TX, USA), reverse transcribed into cDNA (M-
MLV-Reverse Transcriptase, Gibco/BRL, Bethesda, MD,
USA) and cDNA sequences corresponding to the coding
region of nm23 were PCR amplified (primer sequences shown
below). Primer pairs nmHl-l/nmHl-2 and nmHl-3/nmHl-4
were used to amplify the 5' half and the 3' half of nm23-H1
respectively. The reactions were performed with decreasing
annealing temperature (starting at 60'C, going down 1 degree
every second cycle to 56°C, then one cycle at 55'C and one at
54'C followed by 23 cycles at 53'C). PCR products were
purified (Gene Clean-kit, Bio 101, La Jolla, 'CA, USA) and
bound via biotin-streptavidin binding to magnetic particles
(Dynabeads M-280, Dynal, Hamburg, Germany). Single-
stranded templates for sequencing were generated by alkaline
denaturation and magnetic separation of the strands using
the protocol for solid-phase sequencing of Dynal. Sequence
reactions were performed using the Sequenase 2.0 kit of USB
(Cleveland, OH, USA) based on the Sanger dideoxy chain-
termination method.
Loss ofheterozygosity
Loss of nm23 alleles was determined using the chromosomal
marker MPO/q21-23 (Polymeropoulos et al., 1991). PCR
amplification of this region detects a length polymorphism
based on VNTRs (variable number of tandem repeats).
Using primers MPO-1 and MPO-2 (primer sequences shown
below) creates PCR products of 104-110bp depending on
the allele-specific number of dinucleotide repeats. Non-
denaturing polyacrylamide gel electrophoresis for separation
'." Macmillan Press Ltd., 1994 Br. J. Cancer (1994), 70, 1267-12711268 1. HEIDE et al.
in metastases of colorectal
Per cent
UPN Tumour Grade Nm23 tumour
1 L 2-3 1.1 70
2 L 2 1.7 80
3 Ly 2 0.3 70
4 L 1 1.0 80
8 L 2 0.4 100
18 L 2 0.7 90
21 L 2 1.3 80
24 Co 1 1.5 100
24-1 Co 2 0.9 70
24-2 L 3 0.9 80
28 Lu 2 1.0 80
32 L 3 1.1 70
34 L 2 1.1 50
35 L 1 1.4 100
42 Om 2 1.5 80
43 L 1 -2 1.1 50
45 L 3 0.7 100
50 L 2 1.7 100
51 Sk 2 2.1 70
64 L 2 3.4 90
65 L 2 1.3 90
66 L 2-3 3.9 100
72 L 2 1.8 100
L, liver metastasis; Ly, lymph node metastasis; Lu, lung
metastasis; Om, omentum metastasis; Sk, skin metastasis; Co, colon
carcinoma; UPN, unit patient number. The skin metastasis was
derived from a patient with polyposis coli (Rochlitz et al., 1993).
Nm23-mRNA levels related to those of ,-actin. Per cent tumour,
relative tumour cell content estimated on the basis of
haemalum-stained cryostat sections.
of the PCR products was performed with 15% polyacryl-
amide (degree of cross-linking 1:20) at 150 V for 6 h in a
Tris-borate buffer containing 0.089M Tris base, 0.089M
boric acid and 2 mM EDTA (Sambrook et al., 1989).
mRNA expression
Nm23-H1-mRNA concentration was determined using a
differential PCR assay (Frye et al., 1989; Neubauer et al.,
1990): cDNA sequences of the target gene nm23-Hl (primer
pair nmH1-3/nmH1-4) and a reference gene (P-actin) were
co-amplified in the same reaction vessel. The ratio of the
intensities of the two resulting bands indicated the relative
gene expression of nm23-H1. Quantitation of PCR products
was performed via determination of the optical density at
260 nm after separation of the PCR products by means of
HPLC, using the TSK-DEAE-NPR column of Perkin Elmer
Cetus.
Primer sequences
nmHl-l
nmH1-2
nmH1-3
nmH1-4
P-Actin-5'
P-Actin-3'
MPO-1
MPO-2
5'-CCGCAGTTCAAACCTAAGCA-3'
5'-CAACGTAGTGTTCCTTGAGAA-3'
5'-TGTTGGTCTGAAATTCATGCAA-3'
5'-AAAGCAATGTGGTCTGCCCT-3'
5'-CCTTCCTGGGCATGGAGTCCT-3'
5'-GGAGCAATGATCTTGATCTTC-3'
5'-TCCCAGATCGCTCTACATGA-3'
5'-CACAGCTTCAGAAGTCACAG-3'
The P-actin and MPO primer sequences were taken as
described (O'Bryan et al., 1991; Polymeropoulos et al.,
1991).
Results
Sequence analysis
With the aid of the primer pairs NmH 1-1/NmH1-2 and
NmH1-3/NmH1-4, PCR products were generated which
spanned the whole coding region of nm23-H1. Direct sequenc-
ing of these PCR products revealed no genetic alteration in
the nm23-HI coding sequence. Neither point mutations nor
deletions could be detected. Since the sequence was of high
resolving quality over the whole coding region (Figure 1), we
can exclude the possibility of minor mutant bands which
might be weakened by contaminating normal tissue.
In the literature, nucleotide changes that lead to an amino
acid exchange have been described in only two cases. First, a
mutation at amino acid position 48 of nm23-H2, which is
88% identical to nm23-Hl (Stahl et al., 1991), has recently
been found in a childhood neuroblastoma (Leone et al.,
1993). Second, the proline at amino acid position 96 is
homologous to proline 97 of the Drosophila homologue,
which is 78% identical to human nm23-HI (Rosengard et al.,
1989). Mutation of this gene in the Drosophila mutant abnor-
mal wing disc (awd) affects the development of multiple tis-
sues at a stage when the presumptive adult tissues begin to
divide and differentiate (Dearolf et al., 1988). However,
analysing our sequence autoradiographs did not reveal any
mutation in the coding sequence ofnm23-Hl in 22 metastatic
tissues.
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Figure 1 Sequence of nm23-Hl cDNA extending from codon 42
to codon 100 derived from two metastatic liver tissues of two
patients. No mutation could be detected in codons 48 and 96,
which have been described to be mutated in a human neuro-
blastoma and a Drosophila mutant respectively.
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Loss ofheterozygosity
Since many tissue probes available were not Si
perform Southern blots with genomic DNA, we us
based method to detect loss of heterozygosity. Tht
number of alleles present at the nm23 locus
determined using a length polymorphism based
number of tandem repeats (VNTR), flanked by
quences which can be used as primers for PCR
shows an example of several tumour probes togeth
corresponding normal tissues of the same pat
molecular weight of the PCR products was slight
from the expected values of 104-110 bp, which m
result of sequence-specific mobility of short doub
DNA fragments in polyacrylamide gelelectrophos
brook et al., 1989). However, all ten probes v
informative showed two bands in the metastatic a:
the corresponding normal tissue. Since the same
parations of most of these metastases showe
heterozygosity at the p53 locus (I. Heide et al., sul
publication), our results could not be due to con
of the tumour sample with normal tissue. Thi
heterozygosity of the chromosomal region 17q21 is
table at a significant level in metastatic tissues of
tumours.
nm23-HJ mRNA expression
Nm23-H1 mRNA levels were determined with tI
differential PCR assay (Frye et al., 1989; Neub
1990): cDNA sequences of the target gene nm22
reference gene (fi-actin) were co-amplified in the
tion vessel; the ratio of the intensities of the tw
bands indicated the relative gene expression ol
(Figure 3). PCR products were quantified using
resulting values are summarised in Table I. Com
normal colon mucosa the values of the relativi
mRNA expression varied between 0.3 and 3.9;
value of all metastases is 1.4 ± 0.9. Seven of 21
had expression levels higher than 1.5, while two
had relative mRNA levels lower than 0.5. Thus, th
expression levels are only slightly enhanced in
stases compared with normal colon mucosa. 1
densitometry of RNAse-protected autoradiograj
recently been shown that primary colon tumous
pression levels which are significantly higher tha
normal colon mucosa (Myeroff & Markowitz, 1'
authors reported a 4-fold increase in nm23-H1 ml
in non-metastatic as well as in metastatic colob
However, although we also compared our data v
mucosa, the relative expression levels in both studi
be directly comparable owing to different stan
methods.
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Figure 2 Analysis of allelic loss at the 17q21-23 locus
by a length polymorphism owing to a variable number
repeats (VNTR) located in the vicinity of nm23-Hl. (
phoresis of PCR products after amplification using pri:
ing this VNTR region is shown. PCR products o
genomic DNA extracted from non-metastatic (N) and
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Figure 3 Relative mRNA expression of nm23-H1. The cDNA
sequences of the target gene nm23-HI and a reference gene
(,-actin) were co-amplified in the same reaction vessel. The ratio
of the intensities of the two resulting bands indicated the relative
gene expression of nm23-HI. nj-n3, normal colon mucosa of
three patients with primary colorectal cancer; 1-72, unit patient
numbers used in Table I.
Discussion
Nm23 has been proposed to be a suppressor of the formation
of metastases in human tumours. However, the data pub-
he aid of a lished so far concerning the role of nm23-H1 in metastasis
auer et al., formation of colorectal tumours are contradictory. While
3-H1 and a some groups have presented data that suggest an involvement
same reac- of nm23-H1 mutations in metastasis formation (Wang et al.,
vo resulting 1993), others have found no evidence of mutations (Myeroff
f nm23-H1 & Markowitz, 1993). Since all these studies have been per-
HPLC; the formed with primary tumours, subpopulations of cells with
ipared with metastatic potential carrying alterations of nm23 might have
e nm23-H1 been present but undetectable by molecular analysis. Further-
the mean more, the only study on metastatic tissue published so far did
metastases not discriminate between nm23-H1 and nm23-H2 expression
metastases (Ayhan et al., 1993). This, however, seems necessary to meet
te nm23-Hl different functions of both genes in the cell (Postel et al.,
liver meta- 1993). Therefore, using nm23-H1-specific primers, we
Using laser analysed nm23-H1 in metastatic tissue. To improve the sen-
phs, it has sitivity of detection of point mutations, we did not use rapid
rs have ex- screening methods to search for mutations (SSCP analysis or
tn those of RNAse protection assay). Instead we used direct sequencing
993). These of the nm23-H1 coding region, since the sequencing ap-
RNA levels proach provides maximum sensitivity for detecting point
n tumours. mutations in single codons. However, we did not find any
vith normal mutation in the whole coding region of nm23-H1 in meta-
ies may not stases of colorectal cancer. These results taken together with
dardisation those published on primary colon cancer reveal that point
mutations of nm23-H1 are very rare events in colorectal
tumour progression.
Furthermore, we used a very sensitive and reliable PCR
assay to quantify nm23-Hl mRNA levels (Frye et al., 1989;
Neubauer et al., 1990). Using this assay we found that only a
third (7 of 21) of the probes analysed had relative expression
levels which exceeded 1.5. Our results differ from those pub-
lished recently on primary colon cancer with respect to fre-
- 123 bp quency ofoverexpression and mRNA levels (Myeroff & Mar-
- 104 bp kowitz, 1993) which could be because of the different
methods used by these authors. However, our data also
provide evidence in favour of overexpression rather than
underexpression, which seems to be in contrast to the sup-
posed role of nm23-H1 as a metastasis suppressor. This is
reminiscent of the tumour-suppressor protein p53, over-
expression of mutated forms of which results in complex
dtoftandem formation with wild-type p53, thereby abrogating wild-type
3el electro- suppressor function (Levine et al., 1991). However, since we
mers flank- did not find any mutation, overexpression of nm23-H1 could
,f 10 ng of not be explained by such dominant negative effects. Further-
metastatic more, cell clones isolated from human colon carcinomas have
ft and right been shown to express similar levels of nm23-H1 mRNA
regardless of metastatic potential in nude mice (Radinsky et1270 I. HEIDE et al.
al., 1992). Thus, the significance of overexpression of nm23-
HI in the course of tumour progression has to be questioned
in colorectal carcinogenesis.
Although allelic deletions of nm23-Hl in primary colon
tumours have been associated with distant metastases (Cohn
et al., 1991) we were unable to detect loss of heterozygosity
at the 17q21-23 locus in metastases. This could be because
of the chromosomal marker we used in this study, which is
not localised directly at the nm23-H1 locus but at the nearby
MPO locus (Polymeropoulos et al., 1991). However, since
allelic deletions found in human tumours frequently comprise
large chromosomal regions, it is remarkable, that none of the
ten probes we analysed showed loss of heterozygosity at the
17q21-23 locus. Since several important genes that undergo
frequent rearrangements and presumably play a role in
tumorigenesis also map to 17q21 (Backer et al., 1993) nm23-
HI may not be the primary target of allelic deletion in
colorectal tumours.
Thus, the importance of nm23 in tumour progression of
colorectal cancer has to be questioned. The data published so
far indicate that, at least in some tumour types, including
colon cancer, nm23 does not play a major role in the sup-
pression of metastasis. However, it may be possible that
metastasis suppression by nm23 is a tissue-specific pheno-
menon which occurs only in some tumour types via nm23,
while other tissues use different pathways.
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